FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

781124007: Moxetumomab pasudotox (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3744979010 Moxetumomab pasudotox en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3744980013 Moxetumomab pasudotox (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3744979010 Moxetumomab pasudotox en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3744980013 Moxetumomab pasudotox (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moxetumomab pasudotox Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Moxetumomab pasudotox Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only moxetumomab pasudotox (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxetumomab pasudotox Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing moxetumomab pasudotox in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxetumomab pasudotox Inferred relationship Existential restriction modifier (core metadata concept) 1
Moxetumomab pasudotox-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxetumomab pasudotox Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only moxetumomab pasudotox in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxetumomab pasudotox Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start